Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The immune regulation of BCL3 in glioblastoma with mutated IDH1.

Aging - 29 Apr 2022

Fan Shibing, Wu Na, Chang Shichuan, Chen Long, Sun Xiaochuan

Abstract excerpt

BACKGROUND: Glioblastoma in the brain is the most malignant solid tumor with a poor prognosis. Screening critical targets and exploring underlying mechanisms will be a benefit for diagnoses and treatment. IDH1 mutation (R132) was used to distinguish glioblastoma grade and predict prognosis as a significant marker. However, the manner of IDH1 mutation regulating glioblastoma development was still unclear. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to DNA Copy Number Variations
Share to Fatty Acid-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 35488886
DOI: 10.18632/aging.204048
PMCID: PMC9134951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The immune regulation of BCL3 in glioblastoma with mutated IDH1.PMID 35488886Read ↗

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.Semantic proximity Read ↗

Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas.Semantic proximity Read ↗

Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma.Semantic proximity Read ↗

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.Semantic proximity Read ↗

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade GliomaSemantic proximity Read ↗

Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China.Semantic proximity Read ↗

Natural evolution mechanisms of the IDH mutant glioma revealed by multi-omics sequencing of a long-term survivorSemantic proximity Read ↗

CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironmentSemantic proximity Read ↗

FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity Read ↗

The R132H mutation in IDH 1 promotes the recruitment of NK cells through CX 3 CL 1/ CX 3 CR 1 chemotaxis and is correlated with a better prognosis in gliomasSemantic proximity Read ↗

PDIA3 correlates with clinical malignant features and immune signature in human gliomas.Semantic proximity Read ↗

Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.